Ocular toxicity and functional vision recovery in a patient treated with hydroxychloroquine

Reumatol Clin. 2015 May-Jun;11(3):170-3. doi: 10.1016/j.reuma.2014.06.002. Epub 2014 Aug 7.

Abstract

We report the case of a 64-year-old woman with rheumatoid arthritis and Sjögren's syndrome, treated during 48 months with hydroxychloroquine that was removed after an ophthalmological evaluation showed bilateral vision loss associated with paracentral scotoma in the visual field, fundoscopic macular pigmentary changes, and severely impaired central multifocal electrorretinogram (mfERG). Twelve months after treatment withdrawal, visual acuity and central mfERG had surprisingly improved. This is an unusual case of functional recovery after treatment withdrawal. We consider that central mfERG is a more sensitive test than pattern electrorretinogram in the detection of retinal toxicity and functional vision recovery after hydroxychloroquine treatment cessation.

Keywords: Hidroxicloroquina; Hydroxyclhoroquine; Maculopathy; Maculopatía; Recuperación visual; Vision recovery.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / therapeutic use
  • Middle Aged
  • Recovery of Function
  • Sjogren's Syndrome / drug therapy*
  • Vision Disorders / chemically induced*
  • Vision Disorders / diagnosis

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine